ARCHIVES

Solomon Garb’s Questions/Answers

This article is from The Cancer Letter archive.

Vol. 07 No. 02 | January 9, 1981

Download PDF Visit The Full Archive

Related Articles

Advanced Ovarian Cancer Responds To Irofulven In Phase II Studies

October 26, 2001

In This Issue: Congressional Testimony On NIH, NCI Appropriations, FDA Reform

May 9, 1997

FDA Approves Two PSA Tests By roche; Onconase Gets EU Orphan Designation.

March 2, 2001

U.S., Canada Begin ExCel Trial To Evaluate Aromasin For Breast Cancer Prevention

April 29, 2005

FDA Allows Firms To Distribute Reprints On Unapproved Uses of Products

January 16, 2009

NCI Issues 8 Awards, 12 Feasibility Grants, In New SPORE Program

October 9, 1992